The following information is based on a press release from Active Biotech AB (Active Biotech) published on November 11, 2016 and may be subject to change.
The board of Active Biotech has decided on a rights issue whereby shareholders are entitled to one (1) new share for every thirteen (13) shares held. The subscription price is SEK 8.00 per share. The scheduled Ex-date is November 17, 2016. NASDAQ Derivatives Markets will carry out a re-calculation of options, forwards and futures in Active Biotech (ACTIB).
For further information please see attached file.